The global Companion Diagnostics (CDx) Development Services market was valued at million in 2024 and is projected to reach US$ million by 2032, at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
We have surveyed the Companion Diagnostics (CDx) Development Services companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Companion Diagnostics (CDx) Development Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Companion Diagnostics (CDx) Development Services. This report contains market size and forecasts of Companion Diagnostics (CDx) Development Services in global, including the following market information:
Global Companion Diagnostics (CDx) Development Services market revenue, 2020-2025, 2026-2032, ($ millions)
Global top five Companion Diagnostics (CDx) Development Services companies in 2024 (%)
Total Market by Segment:
Global Companion Diagnostics (CDx) Development Services market, by Type, 2020-2025, 2026-2032 ($ millions)
Global Companion Diagnostics (CDx) Development Services market segment percentages, by Type, 2024 (%)
Feasibility Studies
Assay Development
Analytical Validation
Clinical Validation
Others
Global Companion Diagnostics (CDx) Development Services market, by Application, 2020-2025, 2026-2032 ($ millions)
Global Companion Diagnostics (CDx) Development Services market segment percentages, by Application, 2024 (%)
Infectious Diseases
Neurological Disorders
Global Companion Diagnostics (CDx) Development Services market, by region and country, 2020-2025, 2026-2032 ($ millions)
Global Companion Diagnostics (CDx) Development Services market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Companion Diagnostics (CDx) Development Services revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Companion Diagnostics (CDx) Development Services revenues share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Geneuity-Clinical Research Services
Interpace Biosciences
Labcorp
Quest Diagnostics
Q� Solutions
ResearchDx
Almac Diagnostic Services
Biocartis
Cerba Research
Eurofins Scientific
MLM Medical Labs
Qiagen
BGI Genomics
MEDx Translational Medicine
Medical Biological Laboratories (MBL)
Novogene
Outline of Major Chapters:
Chapter 1: Introduces the definition of Companion Diagnostics (CDx) Development Services, market overview.
Chapter 2: Global Companion Diagnostics (CDx) Development Services market size in revenue.
Chapter 3: Detailed analysis of Companion Diagnostics (CDx) Development Services company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Companion Diagnostics (CDx) Development Services in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Companion Diagnostics (CDx) Development Services Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Companion Diagnostics (CDx) Development Services Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Companion Diagnostics (CDx) Development Services Overall Market Size
2.1 Global Companion Diagnostics (CDx) Development Services Market Size: 2024 VS 2032
2.2 Global Companion Diagnostics (CDx) Development Services Market Size, Prospects & Forecasts: 2020-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Companion Diagnostics (CDx) Development Services Players in Global Market
3.2 Top Global Companion Diagnostics (CDx) Development Services Companies Ranked by Revenue
3.3 Global Companion Diagnostics (CDx) Development Services Revenue by Companies
3.4 Top 3 and Top 5 Companion Diagnostics (CDx) Development Services Companies in Global Market, by Revenue in 2024
3.5 Global Companies Companion Diagnostics (CDx) Development Services Product Type
3.6 Tier 1, Tier 2, and Tier 3 Companion Diagnostics (CDx) Development Services Players in Global Market
3.6.1 List of Global Tier 1 Companion Diagnostics (CDx) Development Services Companies
3.6.2 List of Global Tier 2 and Tier 3 Companion Diagnostics (CDx) Development Services Companies
4 Sights by Product
4.1 Overview
4.1.1 Segmentation by Type - Global Companion Diagnostics (CDx) Development Services Market Size Markets, 2024 & 2032
4.1.2 Feasibility Studies
4.1.3 Assay Development
4.1.4 Analytical Validation
4.1.5 Clinical Validation
4.1.6 Others
4.2 Segmentation by Type - Global Companion Diagnostics (CDx) Development Services Revenue & Forecasts
4.2.1 Segmentation by Type - Global Companion Diagnostics (CDx) Development Services Revenue, 2020-2025
4.2.2 Segmentation by Type - Global Companion Diagnostics (CDx) Development Services Revenue, 2026-2032
4.2.3 Segmentation by Type - Global Companion Diagnostics (CDx) Development Services Revenue Market Share, 2020-2032
5 Sights by Application
5.1 Overview
5.1.1 Segmentation by Application - Global Companion Diagnostics (CDx) Development Services Market Size, 2024 & 2032
5.1.2 Infectious Diseases
5.1.3 Neurological Disorders
5.2 Segmentation by Application - Global Companion Diagnostics (CDx) Development Services Revenue & Forecasts
5.2.1 Segmentation by Application - Global Companion Diagnostics (CDx) Development Services Revenue, 2020-2025
5.2.2 Segmentation by Application - Global Companion Diagnostics (CDx) Development Services Revenue, 2026-2032
5.2.3 Segmentation by Application - Global Companion Diagnostics (CDx) Development Services Revenue Market Share, 2020-2032
6 Sights by Region
6.1 By Region - Global Companion Diagnostics (CDx) Development Services Market Size, 2024 & 2032
6.2 By Region - Global Companion Diagnostics (CDx) Development Services Revenue & Forecasts
6.2.1 By Region - Global Companion Diagnostics (CDx) Development Services Revenue, 2020-2025
6.2.2 By Region - Global Companion Diagnostics (CDx) Development Services Revenue, 2026-2032
6.2.3 By Region - Global Companion Diagnostics (CDx) Development Services Revenue Market Share, 2020-2032
6.3 North America
6.3.1 By Country - North America Companion Diagnostics (CDx) Development Services Revenue, 2020-2032
6.3.2 United States Companion Diagnostics (CDx) Development Services Market Size, 2020-2032
6.3.3 Canada Companion Diagnostics (CDx) Development Services Market Size, 2020-2032
6.3.4 Mexico Companion Diagnostics (CDx) Development Services Market Size, 2020-2032
6.4 Europe
6.4.1 By Country - Europe Companion Diagnostics (CDx) Development Services Revenue, 2020-2032
6.4.2 Germany Companion Diagnostics (CDx) Development Services Market Size, 2020-2032
6.4.3 France Companion Diagnostics (CDx) Development Services Market Size, 2020-2032
6.4.4 U.K. Companion Diagnostics (CDx) Development Services Market Size, 2020-2032
6.4.5 Italy Companion Diagnostics (CDx) Development Services Market Size, 2020-2032
6.4.6 Russia Companion Diagnostics (CDx) Development Services Market Size, 2020-2032
6.4.7 Nordic Countries Companion Diagnostics (CDx) Development Services Market Size, 2020-2032
6.4.8 Benelux Companion Diagnostics (CDx) Development Services Market Size, 2020-2032
6.5 Asia
6.5.1 By Region - Asia Companion Diagnostics (CDx) Development Services Revenue, 2020-2032
6.5.2 China Companion Diagnostics (CDx) Development Services Market Size, 2020-2032
6.5.3 Japan Companion Diagnostics (CDx) Development Services Market Size, 2020-2032
6.5.4 South Korea Companion Diagnostics (CDx) Development Services Market Size, 2020-2032
6.5.5 Southeast Asia Companion Diagnostics (CDx) Development Services Market Size, 2020-2032
6.5.6 India Companion Diagnostics (CDx) Development Services Market Size, 2020-2032
6.6 South America
6.6.1 By Country - South America Companion Diagnostics (CDx) Development Services Revenue, 2020-2032
6.6.2 Brazil Companion Diagnostics (CDx) Development Services Market Size, 2020-2032
6.6.3 Argentina Companion Diagnostics (CDx) Development Services Market Size, 2020-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Companion Diagnostics (CDx) Development Services Revenue, 2020-2032
6.7.2 Turkey Companion Diagnostics (CDx) Development Services Market Size, 2020-2032
6.7.3 Israel Companion Diagnostics (CDx) Development Services Market Size, 2020-2032
6.7.4 Saudi Arabia Companion Diagnostics (CDx) Development Services Market Size, 2020-2032
6.7.5 UAE Companion Diagnostics (CDx) Development Services Market Size, 2020-2032
7 Companies Profiles
7.1 Geneuity-Clinical Research Services
7.1.1 Geneuity-Clinical Research Services Corporate Summary
7.1.2 Geneuity-Clinical Research Services Business Overview
7.1.3 Geneuity-Clinical Research Services Companion Diagnostics (CDx) Development Services Major Product Offerings
7.1.4 Geneuity-Clinical Research Services Companion Diagnostics (CDx) Development Services Revenue in Global Market (2020-2025)
7.1.5 Geneuity-Clinical Research Services Key News & Latest Developments
7.2 Interpace Biosciences
7.2.1 Interpace Biosciences Corporate Summary
7.2.2 Interpace Biosciences Business Overview
7.2.3 Interpace Biosciences Companion Diagnostics (CDx) Development Services Major Product Offerings
7.2.4 Interpace Biosciences Companion Diagnostics (CDx) Development Services Revenue in Global Market (2020-2025)
7.2.5 Interpace Biosciences Key News & Latest Developments
7.3 Labcorp
7.3.1 Labcorp Corporate Summary
7.3.2 Labcorp Business Overview
7.3.3 Labcorp Companion Diagnostics (CDx) Development Services Major Product Offerings
7.3.4 Labcorp Companion Diagnostics (CDx) Development Services Revenue in Global Market (2020-2025)
7.3.5 Labcorp Key News & Latest Developments
7.4 Quest Diagnostics
7.4.1 Quest Diagnostics Corporate Summary
7.4.2 Quest Diagnostics Business Overview
7.4.3 Quest Diagnostics Companion Diagnostics (CDx) Development Services Major Product Offerings
7.4.4 Quest Diagnostics Companion Diagnostics (CDx) Development Services Revenue in Global Market (2020-2025)
7.4.5 Quest Diagnostics Key News & Latest Developments
7.5 Q� Solutions
7.5.1 Q� Solutions Corporate Summary
7.5.2 Q� Solutions Business Overview
7.5.3 Q� Solutions Companion Diagnostics (CDx) Development Services Major Product Offerings
7.5.4 Q� Solutions Companion Diagnostics (CDx) Development Services Revenue in Global Market (2020-2025)
7.5.5 Q� Solutions Key News & Latest Developments
7.6 ResearchDx
7.6.1 ResearchDx Corporate Summary
7.6.2 ResearchDx Business Overview
7.6.3 ResearchDx Companion Diagnostics (CDx) Development Services Major Product Offerings
7.6.4 ResearchDx Companion Diagnostics (CDx) Development Services Revenue in Global Market (2020-2025)
7.6.5 ResearchDx Key News & Latest Developments
7.7 Almac Diagnostic Services
7.7.1 Almac Diagnostic Services Corporate Summary
7.7.2 Almac Diagnostic Services Business Overview
7.7.3 Almac Diagnostic Services Companion Diagnostics (CDx) Development Services Major Product Offerings
7.7.4 Almac Diagnostic Services Companion Diagnostics (CDx) Development Services Revenue in Global Market (2020-2025)
7.7.5 Almac Diagnostic Services Key News & Latest Developments
7.8 Biocartis
7.8.1 Biocartis Corporate Summary
7.8.2 Biocartis Business Overview
7.8.3 Biocartis Companion Diagnostics (CDx) Development Services Major Product Offerings
7.8.4 Biocartis Companion Diagnostics (CDx) Development Services Revenue in Global Market (2020-2025)
7.8.5 Biocartis Key News & Latest Developments
7.9 Cerba Research
7.9.1 Cerba Research Corporate Summary
7.9.2 Cerba Research Business Overview
7.9.3 Cerba Research Companion Diagnostics (CDx) Development Services Major Product Offerings
7.9.4 Cerba Research Companion Diagnostics (CDx) Development Services Revenue in Global Market (2020-2025)
7.9.5 Cerba Research Key News & Latest Developments
7.10 Eurofins Scientific
7.10.1 Eurofins Scientific Corporate Summary
7.10.2 Eurofins Scientific Business Overview
7.10.3 Eurofins Scientific Companion Diagnostics (CDx) Development Services Major Product Offerings
7.10.4 Eurofins Scientific Companion Diagnostics (CDx) Development Services Revenue in Global Market (2020-2025)
7.10.5 Eurofins Scientific Key News & Latest Developments
7.11 MLM Medical Labs
7.11.1 MLM Medical Labs Corporate Summary
7.11.2 MLM Medical Labs Business Overview
7.11.3 MLM Medical Labs Companion Diagnostics (CDx) Development Services Major Product Offerings
7.11.4 MLM Medical Labs Companion Diagnostics (CDx) Development Services Revenue in Global Market (2020-2025)
7.11.5 MLM Medical Labs Key News & Latest Developments
7.12 Qiagen
7.12.1 Qiagen Corporate Summary
7.12.2 Qiagen Business Overview
7.12.3 Qiagen Companion Diagnostics (CDx) Development Services Major Product Offerings
7.12.4 Qiagen Companion Diagnostics (CDx) Development Services Revenue in Global Market (2020-2025)
7.12.5 Qiagen Key News & Latest Developments
7.13 BGI Genomics
7.13.1 BGI Genomics Corporate Summary
7.13.2 BGI Genomics Business Overview
7.13.3 BGI Genomics Companion Diagnostics (CDx) Development Services Major Product Offerings
7.13.4 BGI Genomics Companion Diagnostics (CDx) Development Services Revenue in Global Market (2020-2025)
7.13.5 BGI Genomics Key News & Latest Developments
7.14 MEDx Translational Medicine
7.14.1 MEDx Translational Medicine Corporate Summary
7.14.2 MEDx Translational Medicine Business Overview
7.14.3 MEDx Translational Medicine Companion Diagnostics (CDx) Development Services Major Product Offerings
7.14.4 MEDx Translational Medicine Companion Diagnostics (CDx) Development Services Revenue in Global Market (2020-2025)
7.14.5 MEDx Translational Medicine Key News & Latest Developments
7.15 Medical Biological Laboratories (MBL)
7.15.1 Medical Biological Laboratories (MBL) Corporate Summary
7.15.2 Medical Biological Laboratories (MBL) Business Overview
7.15.3 Medical Biological Laboratories (MBL) Companion Diagnostics (CDx) Development Services Major Product Offerings
7.15.4 Medical Biological Laboratories (MBL) Companion Diagnostics (CDx) Development Services Revenue in Global Market (2020-2025)
7.15.5 Medical Biological Laboratories (MBL) Key News & Latest Developments
7.16 Novogene
7.16.1 Novogene Corporate Summary
7.16.2 Novogene Business Overview
7.16.3 Novogene Companion Diagnostics (CDx) Development Services Major Product Offerings
7.16.4 Novogene Companion Diagnostics (CDx) Development Services Revenue in Global Market (2020-2025)
7.16.5 Novogene Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Companion Diagnostics (CDx) Development Services Market Opportunities & Trends in Global Market
Table 2. Companion Diagnostics (CDx) Development Services Market Drivers in Global Market
Table 3. Companion Diagnostics (CDx) Development Services Market Restraints in Global Market
Table 4. Key Players of Companion Diagnostics (CDx) Development Services in Global Market
Table 5. Top Companion Diagnostics (CDx) Development Services Players in Global Market, Ranking by Revenue (2024)
Table 6. Global Companion Diagnostics (CDx) Development Services Revenue by Companies, (US$, Mn), 2020-2025
Table 7. Global Companion Diagnostics (CDx) Development Services Revenue Share by Companies, 2020-2025
Table 8. Global Companies Companion Diagnostics (CDx) Development Services Product Type
Table 9. List of Global Tier 1 Companion Diagnostics (CDx) Development Services Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Companion Diagnostics (CDx) Development Services Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segmentation by Type � Global Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2024 & 2032
Table 12. Segmentation by Type - Global Companion Diagnostics (CDx) Development Services Revenue (US$, Mn), 2020-2025
Table 13. Segmentation by Type - Global Companion Diagnostics (CDx) Development Services Revenue (US$, Mn), 2026-2032
Table 14. Segmentation by Application� Global Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2024 & 2032
Table 15. Segmentation by Application - Global Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2020-2025
Table 16. Segmentation by Application - Global Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2026-2032
Table 17. By Region� Global Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2024 & 2032
Table 18. By Region - Global Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2020-2025
Table 19. By Region - Global Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2026-2032
Table 20. By Country - North America Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2020-2025
Table 21. By Country - North America Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2026-2032
Table 22. By Country - Europe Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2020-2025
Table 23. By Country - Europe Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2026-2032
Table 24. By Region - Asia Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2020-2025
Table 25. By Region - Asia Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2026-2032
Table 26. By Country - South America Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2020-2025
Table 27. By Country - South America Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2026-2032
Table 28. By Country - Middle East & Africa Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2020-2025
Table 29. By Country - Middle East & Africa Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2026-2032
Table 30. Geneuity-Clinical Research Services Corporate Summary
Table 31. Geneuity-Clinical Research Services Companion Diagnostics (CDx) Development Services Product Offerings
Table 32. Geneuity-Clinical Research Services Companion Diagnostics (CDx) Development Services Revenue (US$, Mn) & (2020-2025)
Table 33. Geneuity-Clinical Research Services Key News & Latest Developments
Table 34. Interpace Biosciences Corporate Summary
Table 35. Interpace Biosciences Companion Diagnostics (CDx) Development Services Product Offerings
Table 36. Interpace Biosciences Companion Diagnostics (CDx) Development Services Revenue (US$, Mn) & (2020-2025)
Table 37. Interpace Biosciences Key News & Latest Developments
Table 38. Labcorp Corporate Summary
Table 39. Labcorp Companion Diagnostics (CDx) Development Services Product Offerings
Table 40. Labcorp Companion Diagnostics (CDx) Development Services Revenue (US$, Mn) & (2020-2025)
Table 41. Labcorp Key News & Latest Developments
Table 42. Quest Diagnostics Corporate Summary
Table 43. Quest Diagnostics Companion Diagnostics (CDx) Development Services Product Offerings
Table 44. Quest Diagnostics Companion Diagnostics (CDx) Development Services Revenue (US$, Mn) & (2020-2025)
Table 45. Quest Diagnostics Key News & Latest Developments
Table 46. Q� Solutions Corporate Summary
Table 47. Q� Solutions Companion Diagnostics (CDx) Development Services Product Offerings
Table 48. Q� Solutions Companion Diagnostics (CDx) Development Services Revenue (US$, Mn) & (2020-2025)
Table 49. Q� Solutions Key News & Latest Developments
Table 50. ResearchDx Corporate Summary
Table 51. ResearchDx Companion Diagnostics (CDx) Development Services Product Offerings
Table 52. ResearchDx Companion Diagnostics (CDx) Development Services Revenue (US$, Mn) & (2020-2025)
Table 53. ResearchDx Key News & Latest Developments
Table 54. Almac Diagnostic Services Corporate Summary
Table 55. Almac Diagnostic Services Companion Diagnostics (CDx) Development Services Product Offerings
Table 56. Almac Diagnostic Services Companion Diagnostics (CDx) Development Services Revenue (US$, Mn) & (2020-2025)
Table 57. Almac Diagnostic Services Key News & Latest Developments
Table 58. Biocartis Corporate Summary
Table 59. Biocartis Companion Diagnostics (CDx) Development Services Product Offerings
Table 60. Biocartis Companion Diagnostics (CDx) Development Services Revenue (US$, Mn) & (2020-2025)
Table 61. Biocartis Key News & Latest Developments
Table 62. Cerba Research Corporate Summary
Table 63. Cerba Research Companion Diagnostics (CDx) Development Services Product Offerings
Table 64. Cerba Research Companion Diagnostics (CDx) Development Services Revenue (US$, Mn) & (2020-2025)
Table 65. Cerba Research Key News & Latest Developments
Table 66. Eurofins Scientific Corporate Summary
Table 67. Eurofins Scientific Companion Diagnostics (CDx) Development Services Product Offerings
Table 68. Eurofins Scientific Companion Diagnostics (CDx) Development Services Revenue (US$, Mn) & (2020-2025)
Table 69. Eurofins Scientific Key News & Latest Developments
Table 70. MLM Medical Labs Corporate Summary
Table 71. MLM Medical Labs Companion Diagnostics (CDx) Development Services Product Offerings
Table 72. MLM Medical Labs Companion Diagnostics (CDx) Development Services Revenue (US$, Mn) & (2020-2025)
Table 73. MLM Medical Labs Key News & Latest Developments
Table 74. Qiagen Corporate Summary
Table 75. Qiagen Companion Diagnostics (CDx) Development Services Product Offerings
Table 76. Qiagen Companion Diagnostics (CDx) Development Services Revenue (US$, Mn) & (2020-2025)
Table 77. Qiagen Key News & Latest Developments
Table 78. BGI Genomics Corporate Summary
Table 79. BGI Genomics Companion Diagnostics (CDx) Development Services Product Offerings
Table 80. BGI Genomics Companion Diagnostics (CDx) Development Services Revenue (US$, Mn) & (2020-2025)
Table 81. BGI Genomics Key News & Latest Developments
Table 82. MEDx Translational Medicine Corporate Summary
Table 83. MEDx Translational Medicine Companion Diagnostics (CDx) Development Services Product Offerings
Table 84. MEDx Translational Medicine Companion Diagnostics (CDx) Development Services Revenue (US$, Mn) & (2020-2025)
Table 85. MEDx Translational Medicine Key News & Latest Developments
Table 86. Medical Biological Laboratories (MBL) Corporate Summary
Table 87. Medical Biological Laboratories (MBL) Companion Diagnostics (CDx) Development Services Product Offerings
Table 88. Medical Biological Laboratories (MBL) Companion Diagnostics (CDx) Development Services Revenue (US$, Mn) & (2020-2025)
Table 89. Medical Biological Laboratories (MBL) Key News & Latest Developments
Table 90. Novogene Corporate Summary
Table 91. Novogene Companion Diagnostics (CDx) Development Services Product Offerings
Table 92. Novogene Companion Diagnostics (CDx) Development Services Revenue (US$, Mn) & (2020-2025)
Table 93. Novogene Key News & Latest Developments
List of Figures
Figure 1. Companion Diagnostics (CDx) Development Services Product Picture
Figure 2. Companion Diagnostics (CDx) Development Services Segment by Type in 2024
Figure 3. Companion Diagnostics (CDx) Development Services Segment by Application in 2024
Figure 4. Global Companion Diagnostics (CDx) Development Services Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Companion Diagnostics (CDx) Development Services Market Size: 2024 VS 2032 (US$, Mn)
Figure 7. Global Companion Diagnostics (CDx) Development Services Revenue: 2020-2032 (US$, Mn)
Figure 8. The Top 3 and 5 Players Market Share by Companion Diagnostics (CDx) Development Services Revenue in 2024
Figure 9. Segmentation by Type � Global Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2024 & 2032
Figure 10. Segmentation by Type - Global Companion Diagnostics (CDx) Development Services Revenue Market Share, 2020-2032
Figure 11. Segmentation by Application � Global Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2024 & 2032
Figure 12. Segmentation by Application - Global Companion Diagnostics (CDx) Development Services Revenue Market Share, 2020-2032
Figure 13. By Region - Global Companion Diagnostics (CDx) Development Services Revenue Market Share, 2020-2032
Figure 14. By Country - North America Companion Diagnostics (CDx) Development Services Revenue Market Share, 2020-2032
Figure 15. United States Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2020-2032
Figure 16. Canada Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2020-2032
Figure 17. Mexico Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2020-2032
Figure 18. By Country - Europe Companion Diagnostics (CDx) Development Services Revenue Market Share, 2020-2032
Figure 19. Germany Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2020-2032
Figure 20. France Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2020-2032
Figure 21. U.K. Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2020-2032
Figure 22. Italy Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2020-2032
Figure 23. Russia Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2020-2032
Figure 24. Nordic Countries Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2020-2032
Figure 25. Benelux Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2020-2032
Figure 26. By Region - Asia Companion Diagnostics (CDx) Development Services Revenue Market Share, 2020-2032
Figure 27. China Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2020-2032
Figure 28. Japan Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2020-2032
Figure 29. South Korea Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2020-2032
Figure 30. Southeast Asia Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2020-2032
Figure 31. India Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2020-2032
Figure 32. By Country - South America Companion Diagnostics (CDx) Development Services Revenue Market Share, 2020-2032
Figure 33. Brazil Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2020-2032
Figure 34. Argentina Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2020-2032
Figure 35. By Country - Middle East & Africa Companion Diagnostics (CDx) Development Services Revenue Market Share, 2020-2032
Figure 36. Turkey Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2020-2032
Figure 37. Israel Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2020-2032
Figure 38. Saudi Arabia Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2020-2032
Figure 39. UAE Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2020-2032
Figure 40. Geneuity-Clinical Research Services Companion Diagnostics (CDx) Development Services Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 41. Interpace Biosciences Companion Diagnostics (CDx) Development Services Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 42. Labcorp Companion Diagnostics (CDx) Development Services Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 43. Quest Diagnostics Companion Diagnostics (CDx) Development Services Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 44. Q� Solutions Companion Diagnostics (CDx) Development Services Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 45. ResearchDx Companion Diagnostics (CDx) Development Services Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 46. Almac Diagnostic Services Companion Diagnostics (CDx) Development Services Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 47. Biocartis Companion Diagnostics (CDx) Development Services Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 48. Cerba Research Companion Diagnostics (CDx) Development Services Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 49. Eurofins Scientific Companion Diagnostics (CDx) Development Services Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 50. MLM Medical Labs Companion Diagnostics (CDx) Development Services Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 51. Qiagen Companion Diagnostics (CDx) Development Services Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 52. BGI Genomics Companion Diagnostics (CDx) Development Services Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 53. MEDx Translational Medicine Companion Diagnostics (CDx) Development Services Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 54. Medical Biological Laboratories (MBL) Companion Diagnostics (CDx) Development Services Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 55. Novogene Companion Diagnostics (CDx) Development Services Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
